| Product Code: ETC12652014 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Leishmaniasis Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Leishmaniasis Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Leishmaniasis Market - Industry Life Cycle |
3.4 Ireland Leishmaniasis Market - Porter's Five Forces |
3.5 Ireland Leishmaniasis Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 Ireland Leishmaniasis Market Revenues & Volume Share, By Diagnosis Method, 2021 & 2031F |
3.7 Ireland Leishmaniasis Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.8 Ireland Leishmaniasis Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Ireland Leishmaniasis Market Revenues & Volume Share, By Research Focus, 2021 & 2031F |
4 Ireland Leishmaniasis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about leishmaniasis in Ireland |
4.2.2 Rising incidence of leishmaniasis cases in the country |
4.2.3 Government initiatives to control and prevent leishmaniasis |
4.3 Market Restraints |
4.3.1 Limited availability of effective treatment options for leishmaniasis |
4.3.2 High treatment costs associated with managing leishmaniasis |
4.3.3 Lack of comprehensive screening and diagnostic tools for early detection |
5 Ireland Leishmaniasis Market Trends |
6 Ireland Leishmaniasis Market, By Types |
6.1 Ireland Leishmaniasis Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Leishmaniasis Market Revenues & Volume, By Disease Type, 2021 - 2031F |
6.1.3 Ireland Leishmaniasis Market Revenues & Volume, By Cutaneous Leishmaniasis, 2021 - 2031F |
6.1.4 Ireland Leishmaniasis Market Revenues & Volume, By Visceral Leishmaniasis, 2021 - 2031F |
6.1.5 Ireland Leishmaniasis Market Revenues & Volume, By Mucocutaneous Leishmaniasis, 2021 - 2031F |
6.1.6 Ireland Leishmaniasis Market Revenues & Volume, By Diffuse Cutaneous Leishmaniasis, 2021 - 2031F |
6.1.7 Ireland Leishmaniasis Market Revenues & Volume, By Post-Kala-Azar Dermal Leishmaniasis, 2021 - 2031F |
6.2 Ireland Leishmaniasis Market, By Diagnosis Method |
6.2.1 Overview and Analysis |
6.2.2 Ireland Leishmaniasis Market Revenues & Volume, By Microscopic Examination, 2021 - 2031F |
6.2.3 Ireland Leishmaniasis Market Revenues & Volume, By Serological Tests, 2021 - 2031F |
6.2.4 Ireland Leishmaniasis Market Revenues & Volume, By PCR Testing, 2021 - 2031F |
6.2.5 Ireland Leishmaniasis Market Revenues & Volume, By Culture Methods, 2021 - 2031F |
6.2.6 Ireland Leishmaniasis Market Revenues & Volume, By Montenegro Skin Test, 2021 - 2031F |
6.3 Ireland Leishmaniasis Market, By Treatment Type |
6.3.1 Overview and Analysis |
6.3.2 Ireland Leishmaniasis Market Revenues & Volume, By Antimonial Compounds, 2021 - 2031F |
6.3.3 Ireland Leishmaniasis Market Revenues & Volume, By Amphotericin B, 2021 - 2031F |
6.3.4 Ireland Leishmaniasis Market Revenues & Volume, By Miltefosine, 2021 - 2031F |
6.3.5 Ireland Leishmaniasis Market Revenues & Volume, By Paromomycin, 2021 - 2031F |
6.3.6 Ireland Leishmaniasis Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.4 Ireland Leishmaniasis Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Ireland Leishmaniasis Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Ireland Leishmaniasis Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4.4 Ireland Leishmaniasis Market Revenues & Volume, By Diagnostic Centers, 2021 - 2031F |
6.4.5 Ireland Leishmaniasis Market Revenues & Volume, By Public Health Organizations, 2021 - 2031F |
6.4.6 Ireland Leishmaniasis Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.5 Ireland Leishmaniasis Market, By Research Focus |
6.5.1 Overview and Analysis |
6.5.2 Ireland Leishmaniasis Market Revenues & Volume, By Parasite Biology, 2021 - 2031F |
6.5.3 Ireland Leishmaniasis Market Revenues & Volume, By Vaccine Development, 2021 - 2031F |
6.5.4 Ireland Leishmaniasis Market Revenues & Volume, By Drug Resistance Mechanisms, 2021 - 2031F |
6.5.5 Ireland Leishmaniasis Market Revenues & Volume, By Vector Control Strategies, 2021 - 2031F |
6.5.6 Ireland Leishmaniasis Market Revenues & Volume, By Epidemiological Studies, 2021 - 2031F |
7 Ireland Leishmaniasis Market Import-Export Trade Statistics |
7.1 Ireland Leishmaniasis Market Export to Major Countries |
7.2 Ireland Leishmaniasis Market Imports from Major Countries |
8 Ireland Leishmaniasis Market Key Performance Indicators |
8.1 Percentage increase in public health campaigns related to leishmaniasis |
8.2 Number of reported leishmaniasis cases in Ireland |
8.3 Funding allocation towards leishmaniasis research and development |
8.4 Adoption rate of preventative measures against leishmaniasis |
8.5 Rate of development and approval of new treatment options |
9 Ireland Leishmaniasis Market - Opportunity Assessment |
9.1 Ireland Leishmaniasis Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 Ireland Leishmaniasis Market Opportunity Assessment, By Diagnosis Method, 2021 & 2031F |
9.3 Ireland Leishmaniasis Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.4 Ireland Leishmaniasis Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Ireland Leishmaniasis Market Opportunity Assessment, By Research Focus, 2021 & 2031F |
10 Ireland Leishmaniasis Market - Competitive Landscape |
10.1 Ireland Leishmaniasis Market Revenue Share, By Companies, 2024 |
10.2 Ireland Leishmaniasis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here